Showing 1 - 20 results of 25 for search '"therapeutics"', query time: 0.07s Refine Results
  1. 1

    Nonruptured intracranial aneurysms: Therapeutic recommendations by Reith, W, Grunwald, I

    Published 2002
    “…This paper trys to review and to discuss the literature and to give guidelines for therapeutic decisions. The decision to treat an unruptured intracranial aeurysm must always comprise the individuell factors such as age, life prognosis, neurological status, and the advantages and disdavantages of the considered method.…”
    Journal article
  2. 2

    [Nonruptured intracranial aneurysms: therapeutic recommendations] by Reith, W, Grunwald, I

    Published 2002
    “…This paper tries to review and to discuss the literature and to give guidelines for therapeutic decisions. The decision to treat an unruptured intracranial aneurysm must always comprise the individual factors such as age, life prognosis, neurological status, and the advantages and disadvantages of the considered method.…”
    Journal article
  3. 3

    [Usher syndrome: clinical features, diagnostic options, and therapeutic prospects]. by Seeliger, M, Fischer, MD, Pfister, M

    Published 2009
    “…The focus of this work is to introduce the typical clinical picture of Usher syndrome, summarize diagnostic options, and give an overview of therapeutic strategies.…”
    Journal article
  4. 4

    Usher syndrome: Clinical features, diagnostic options, and therapeutic prospects by Seeliger, M, Fischer, M, Pfister, M

    Published 2009
    “…The focus of this work is to introduce the typical clinical picture of Usher syndrome, summarize diagnostic options, and give an overview of therapeutic strategies. © 2009 Springer Medizin Verlag.…”
    Journal article
  5. 5

    [Stroke] by Ahlhelm, F, Naumann, N, Haass, A, Grunwald, I, Schulte-Altedorneburg, G, Fassbender, K, Reith, W

    Published 2006
    “…High demands need to be placed on the initial diagnostic work-up and therapeutic treatment to ensure that the patients benefit from the recent advancements achieved in diagnostic and therapeutic fields. …”
    Journal article
  6. 6

    Stroke by Ahlhelm, F, Naumann, N, Haass, A, Grunwald, I, Schulte-Altedorneburg, G, Faßbender, K, Reith, W

    Published 2006
    “…High demands need to be placed on the initial diagnostic work-up and therapeutic treatment to ensure that the patients benefit from the recent advancements achieved in diagnostic and therapeutic fields. …”
    Journal article
  7. 7

    [Sinus and venous thrombosis--differential diagnosis of acute stroke] by Grunwald, I, Politi, M, Holst, B, Dorenbeck, U, Papanagiotou, P, Reith, W

    Published 2005
    “…This contribution addresses the etiology, clinical picture, imaging procedures, and therapeutic options.…”
    Journal article
  8. 8

    Sinus and venous thrombosis - A differential diagnosis of acute stroke by Grunwald, I, Politi, M, Holst, B, Dorenbeck, U, Papanagiotou, P, Reith, W

    Published 2005
    “…This contribution addresses the etiology, clinical picture, imaging procedures, and therapeutic options. © Springer Medizin Verlag 2005.…”
    Journal article
  9. 9

    Outcomes Following Acute Nonvariceal Upper Gastrointestinal Bleeding in Relation to Time to Endoscopy: Results from a Nationwide Study by Jairath, V, Kahan, B, Logan, R, Hearnshaw, SA, Dore, C, Travis, S, Murphy, M, Palmer, K

    Published 2012
    “…Background and study aims: Despite the established efficacy of therapeutic endoscopy, the optimum timeframe for performing endoscopy in patients with nonvariceal upper gastrointestinal bleeding (NVUGIB) remains unclear. …”
    Journal article
  10. 10

    Communicational strategies as a basis for supporting lexical skills by Dohmen, A, Vogt, S

    Published 2004
    “…Finally, a short discussion about possible effects on therapeutic actions and on evaluation will follow.…”
    Journal article
  11. 11

    Dimenhydrinate in children with acute gastroenteritis and vomiting by Uhlig, U, Pfeil, N, Uhlig, H

    Published 2009
    “…In Germany, dimenhydrinate is most frequently prescribed although there is no recommendation by treatment guidelines. So far the therapeutic efficacy of dimenhydrinate has not been shown in children with gastroenteritis and vomiting by randomized controlled trials. …”
    Journal article
  12. 12

    "Fracture liaison" duty service at the clinic Klagenfurt Wörthersee - Initial results of an interdisciplinary project by Mikosch, P, Daskalakis, S, Igerc, I, Matschnig, S, Jerusalem, A, Müller, E, Stöckl, B, Schauss, S, Egarter, K, Jeschofnik, R, Geissler, D, Lind, P, Pinter, G

    Published 2011
    “…The given recommendations tried to include the specific clinical conditions of the patients into the decision making, thus all currently available therapeutic options of osteoporosis therapy were subscribed. …”
    Journal article
  13. 13

    [HIV-associated cerebral toxoplasmosis -- review and retrospective analysis of 36 patients]. by Happe, S, Fischer, A, Heese, C, Reichelt, D, Grüneberg, U, Freund, M, Kloska, S, Evers, S, Husstedt, I

    Published 2002
    “…Before HAART, up to 50% of all HIV-infected patients in Europe developed cerebral toxoplasmosis, an encephalitis caused by reactivation of Toxoplasma gondii infection. Although potent therapeutical options exist, the prognosis is still poor. …”
    Journal article
  14. 14

    The significance of molecular imaging for MRI in neuroradiology by Heckl, S, Pipkorn, R, Nägele, T, Küker, W, Voigt, K

    Published 2003
    “…The main points of interest in neuroradiology are the differentiation between tumor and non-tumor cells with the aid of oncogene profiles, the tracking of transplanted oligodendrocyte progenitor cells for the determination of the extent of remyelinization in the spinal cord and also the assessment of the therapeutic success in apoplexy using subventricular zone cells. …”
    Journal article
  15. 15

    [More than muscle stiffness]. by Trück, J

    Published 2006
    “…Severe complications are hypovolemia, electrolyte disorders, a compartment syndrome, disseminated intravascular coagulation and acute renal failure, which causes death in 20% of the patients, although non-traumatic causes seem to have better outcome. The mainly therapeutic option is to correct the hypovolemia with sufficient fluid supply.…”
    Journal article
  16. 16

    [Thrombolysis of the basilar artery: 5-year results from the Saarland stroke registry] by Grunwald, I, Struffert, T, Roth, C, Papanagiotou, P, Scheuermann, J, Voges, M, Reith, W

    Published 2005
    “…With progressing symptoms the therapeutic window can be stretched up to 12 h, but coma lasting for more than 4 h is related to a bad outcome.…”
    Journal article
  17. 17

    More than just sore muscles: A 4-month-old male patient by Trück, J

    Published 2006
    “…Severe complications are hypovolemia, electrolyte disorders, a compartment syndrome, disseminated intravascular coagulation and acute renal failure, which causes death in 20% of the patients, although non-traumatic causes seem to have better outcome. The mainly therapeutic option is to correct the hypovolemia with sufficient fluid supply. © 2006 by Verlag Hans Huber, Hogrefe AG.…”
    Journal article
  18. 18

    Thrombolysis of the basilar artery: 5-Year results from the Saarland stroke registry by Grunwald, I, Struffert, T, Roth, C, Papanagiotou, P, Scheuermann, J, Voges, M, Reith, W

    Published 2005
    “…With progressing symptoms the therapeutic window can be stretched up to 12 h, but coma lasting for more than 4 h is related to a bad outcome. © Springer Medizin Verlag 2005.…”
    Journal article
  19. 19

    Theta burst stimulation - A possible therapy for neglectpatients? by Nyffeler, T, Müri, R, Cazzoli, D

    Published 2010
    “…The precise mechanisms of action, the duration of the effects, and the relevance for the activities of daily living of current therapeutic approaches are still uncertain. Interhemispheric balance has been shown to play a central role in the occurrence and persistence of hemispatial neglect. …”
    Journal article
  20. 20

    Gentherapie als Behandlungskonzept für erbliche Netzhauterkrankungen [Gene therapy as a treatment concept for inherited retinal diseases] by Bellingrath, J, Fischer, MD

    Published 2015
    “…Gene therapy for inherited retinal diseases (IRDs) is currently being validated in several clinical trials and is becoming a promising therapeutic option for these previously incurable diseases.The aim of this review is to give an overview of the concept, the application and the challenges associated with gene therapy. …”
    Journal article